JUNS vs WRB · rev $21.8K vs P/E 17, rev $3.72B
Jupiter Neurosciences, Inc. Common Stock (JUNS) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
Latest reported WRB revenue for 2026-06-30 was $3.72B. Net income was $452.3M. Revenue was up 0.7% from 2026-03-31 to 2026-06-30. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
JUNS currently screens at market cap $10.0M. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the JUNS and WRB stock pages for the full models.
Not investment advice.